India’s exports of pharmaceuticals during 2022-23 was valued at $25.4 billion with a growth of almost 3.25 percent over the previous financial year, according to Pharmexcil.
India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
Published in Indian Journal of Medical Research, study classifies nearly 10% prescriptions as 'unacceptable', says such lapses can lead to adverse drug reactions & risk patient health.
Swiss drugmaker Roche Pharma says Ocrelizumab can help manage multiple sclerosis & impede disability progression. Doctors welcome launch but caution against potential side effects.
The two drugs – Leqembi and Donanemab – are the first to offer real hope of slowing the fatal disease for 6.5 million Americans living with the disease.
At least 70 children died from acute kidney injury in Gambia last year, cases the WHO linked to medicines made by Indian drugmaker Maiden Pharmaceuticals.
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
In a recent survey of law school admissions officers, 94% said the current political climate in the US played at least a moderate role in the increase.
New CPI series will take 2024 as base year, will provide more accurate measure of inflation, spending on digital services. Expected to enhance representation and reliability, says Saurabh Garg.
The agreement, signed after meeting between Rajnath and US Secretary of War Pete Hegseth on sidelines of ADMM-Plus in Kuala Lumpur, aims to deepen bilateral ties in the critical sector.
On 21 Oct, a buzz went up that the govt had released full list of gallantry award recipients along with Op Sindoor citations. I put an AI caddy on the job. It took me into a never-ending rabbit hole.
COMMENTS